Chronic disease management firm Wellthy Therapeutics on Friday said it has partnered with German life sciences group Bayer G4A to improve its product, regulatory and commercialisation capabilities and explore areas of collaboration.
As part of the partnership, G4A team will work closely with Wellthy Therapeutics to improve its capabilities while exploring areas of collaboration, Wellthy Therapeutics said in a statement.
"We look forward to supporting the advancement of their patient centric, outcomes focused approach to care, and explore opportunities to collaborate," Bayer G4A Digital Health Global Head Eugene Borukhovich said.
Advancements in digital therapeutics over the last few years have been enabling an integrated health approach for and with the patients, he added.
"We are humbled and excited to begin this journey with Bayer, to improve our product, strengthen our company and develop goes to market solutions that accelerate our journey to bring digital therapeutics to patients worldwide," Wellthy Therapeutics CEO and Co-Founder Abhishek Shah said.
Wellthy Therapeutics is on a mission to inspire and enable millions of patients to prevent or manage their chronic condition, he added.
Bayer G4A collaborate with startups and healthcare technology companies that are developing innovative solutions in health and care.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app